Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 266 results for "bse healthcare"

Jaiprakash Associates leads gainers on BSE's 'A' group

Central Bank of India, Firstsource Solutions, Ujjivan Financial Services and Fortis Healthcare are among the other gainers in the BSE's 'A' group today, 30 August 2017. Business Standard, 3 weeks ago
Trent leads gainers in 'A' group Business Standard, 1 day ago
Fortis Healthcare leads losers on BSE's 'A' group Business Standard, 2 months ago

17 images for bse healthcare

Money Control, 2 weeks ago
Sify, 3 weeks ago
Money Today, 4 weeks ago
Sify, 3 weeks ago
Money Control, 2 months ago
Money Control, 2 months ago
Money Control, 2 months ago
Money Control, 3 months ago
Sify, 3 months ago
Money Control, 3 months ago
Money Control

Pharma weekly wrap: Pharma stocks gain on investor interest due to cheap valuations

The BSE Healthcare rose 4.44 percent in the past week, the benchmark Sensex gained 1.49 percent
 Money Control4 days ago Pharma shares extend gain; Sun Pharma, Divi's Lab up over 10% in three days  Business Standard6 days ago This week in pharma: Lupin, Cadila, Strides Shasun get clearances from US FDA  Money Control2 weeks ago Pharma stocks in demand as investors react to some positive news  Sify3 weeks ago
Sify

Cadila Healthcare in pink of health after USFDA nod for influenza drug

Cadila Healthcare rose 1.09% to Rs 486.45 at 14:00 IST on BSE after the company announced that its US subsidiary received final approval from the US drug regulator to market Oseltamivir powder for Oral Suspension, 6 mg/ml.
 Business Standard2 days ago Cadila's Moraiya plant successfully completes USFDA inspection  Business Standard1 week ago Cadila inches up after FDA approval for drug  Business Standard2 weeks ago Cadila Healthcare gains after USFDA approval for drug  Business Standard3 weeks ago
Sify

Fortis Healthcare trims losses, stock down 1% after falling 13% intraday

A combined 19.15 million equity shares changed hands on NSE and BSE till 10:20 am.
 Business Standard4 weeks ago Equities close flat; healthcare, banks stocks in green  Prokerala6 days ago Negative global cues subdue equities; healthcare, FMCG stocks plunge  Sify2 weeks ago Flat Finish to the Week; Cadila Healthcare Rallies 7%  Equitymaster.com3 weeks ago
[x]  
Sify

TTK Healthcare extends post-result losses

TTK Healthcare lost 3.36% to Rs 695 at 10:54 IST on BSE, with the stock extending losses triggered by the company reporting reverse turnaround in Q1.
 Business Standard1 month ago TTK Healthcare slumps after reverse turnaround in Q1  Business Standard1 month ago Hester Biosciences posts Q1 net profit at Rs 6.17 cr  Business Standard1 month ago Biocon's q1 slump adds to misery for pharma stocks  Sify1 month ago
Sify

Returns of BSE Healthcare Index vis a vis Sensex

BSE Healthcare Index is down 24% in two years. This is a mighty fall compared to the benchmark index, which is up 23% during the same period. A downgrade in earnings estimates has led to the selloff in the pharma space. USFDA alerts on Indian pharma companies ...
 Equitymaster.com2 weeks ago Indian shares range-bound; banks, realty gain  Sify4 weeks ago Indian shares fall; Reliance Industries, pharma stocks drag  Sify1 month ago Indian shares fall on profit-taking; financial stocks down  Sify2 months ago

Fortis Healthcare gains as RBI hikes foreign investment ceiling

Fortis Healthcare was up 3.13% to Rs 163.30 at 12:46 IST on BSE after the Reserve Bank of India on Friday, 7 July 2017, approved hiking foreign investment ceiling in the company upto 74% of the paid-up equity capital.
 Business Standard2 months ago Fortis Healthcare gets healthier after buzz of listing diagnostics arm  Business Standard2 months ago Fortis Healthcare slumps after buzz of IHH denying stake buy  Business Standard2 months ago Fortis Healthcare shares slump 13%; mcap dips by Rs 1,315 cr  Business Standard2 months ago

Sensex Finishes Over 240 Points Higher; Metal & Healthcare Stocks Gain Most

Posted by Equitymaster Share markets in India continued their upward climb in afternoon trade. At the closing bell, the BSE Sensex closed higher by 244 points. While, the NSE Nifty finished higher by 72 points. Meanwhile, the S&P BSE Midcap Index and the S&P ...
 Equitymaster.com2 months ago Sensex & Nifty Hit Record Highs; Are Stocks Expensive Now?  Equitymaster.com1 month ago

Sensex gains 93 pts in early trade; RIL, ITC gain

The benchmark BSE Sensex rebounded by over 93 points in early trade today on gains in bluechips such as RIL, L&T and ITC amid a rising trend in Asia. The 30-share index was trading higher by 93.02 points, or 0.28 per cent, at 32,495.39. Sectoral indices led ...
 Deccan Herald17 hours ago
Money Control

Likely competition for generic Lialda bears on Cadila's stocks

Copy Begins/Cadila Healthcare's (Zydus Cadila) blockbuster drug the generic version of mesalamine (Lialda) is likely to face competition from the innovator itself as Irish pharma firm Shire Plc is expected to launch an authorised generic (AG) version of the ...
 Business Standard1 week ago Zydus settles patent case over Aptalis' drug Canasa  Business Standard1 month ago Zydus gets USFDA nod to market Tranexamic acid injection  Business Standard2 months ago Zydus Cadila gets USFDA nod for generic Hepatitis B drug  Business Standard2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less